| Literature DB >> 27127790 |
Yusuke Morita1, Takao Kato1, Mitsumasa Okano1, Kanae Suu1, Masahiro Kimura1, Eri Minamino-Muta1, Eisaku Nakane1, Toshiaki Izumi1, Shoichi Miyamoto1, Tetsuya Haruna1, Koji Ueyama1, Moriaki Inoko1.
Abstract
Introduction. The aim of this study was to examine the incidence and risk factors of catheterization-related CI in the contemporary era, using diffusion-weighted magnetic resonance imaging. Methods. We retrospectively analyzed consecutive 84 patients who underwent MRI (magnetic resonance imaging) after 2.81 ± 2.4 days (mean ± SD) of catheterization via aortic arch. We categorized the patients by the presence or absence of acute CI determined by diffusion-weighted MRI and analyzed the incidence and predictors. Results. Of 84 patients that underwent MRI after catheterization, acute CI was determined in 27 (32.1%) patients. In univariate analysis, dyslipidemia, age, coronary artery disease, antiplatelet agents, number of catheters used, urgent settings, and interventional procedures were significantly different. Multivariate analysis revealed dyslipidemia (odds ratio [OR], 4.46; 95% confidence interval [CI], 1.41-16.03; p = 0.01), higher age (OR, 1.09; 95% CI, 1.007-1.19; p = 0.03), and the number of catheters used (OR, 2.21; 95% CI, 1.21-4.36; p = 0.01) as independent predictors of the incidence of catheterization-related acute CI. Conclusions. Dyslipidemia, higher age, and number of catheters used were independent predictors for acute CI after catheterization. These findings imply that managing dyslipidemia and comprehensive planning to minimize the numbers of catheters are important.Entities:
Mesh:
Year: 2016 PMID: 27127790 PMCID: PMC4835628 DOI: 10.1155/2016/6052125
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The reasons for MRI in the study subjects.
|
| |
|---|---|
| Candidates for coronary artery bypass grafting, % | 31 (26) |
| Candidates for valvular surgery, % | 15.8 (13) |
| Prior syncope, % | 11.9 (10) |
| Assessments for symptoms, % | 11.9 (10) |
| Candidates for pacemaker implantation, % | 6 (5) |
| Candidates for aortic repair, % | 6 (5) |
| Candidates for peripheral vascular surgery, % | 3.6 (3) |
| Others, % | 14.3 (12) |
Figure 1Flowchart of the study population. MRI: magnetic resonance imaging; CI: cerebral infarction.
Baseline characteristics of the study subjects.
| All | CI | No CI |
| |
|---|---|---|---|---|
|
|
|
| ||
| Age, yr | 71.6 ± 8.7 | 74.1 ± 6.6 | 70.4 ± 9.4 | 0.04 |
| Male, % | 61.9 | 66.7 | 59.7 | 0.53 |
| Hypertension, % | 73.8 | 77.8 | 71.9 | 0.57 |
| Dyslipidemia (LDL ≧ 140 mg/dL/statin user), % | 45.2 | 63 | 36.8 | 0.04 |
| LDL ≧ 140 mg/dL, % | 10.7 | 14.8 | 8.8 | 0.46 |
| Diabetes, % | 42.9 | 55.6 | 36.8 | 0.11 |
| Smoking, % | 59.5 | 63 | 57.9 | 0.66 |
| Family history, % | 10.7 | 11.1 | 10.5 | 0.94 |
| Prior stroke, % | 14.3 | 18.5 | 12.3 | 0.45 |
| Prior MI, % | 26.2 | 29.6 | 24.6 | 0.62 |
| MI within 7 days prior, % | 6.0 | 11.1 | 3.5 | 0.17 |
| EF < 40, % | 13.1 | 22.2 | 8.8 | 0.09 |
| PVD, % | 28.6 | 40.7 | 22.8 | 0.09 |
| CAD, % | 60.7 | 77.8 | 52.6 | 0.03 |
| Cre > 1.5 mg/dL, % | 14.3 | 14.8 | 14.4 | 0.92 |
| Severe aortic stenosis, % | 11.9 | 3.7 | 15.8 | 0.11 |
| AF, % | 10.7 | 14.8 | 8.8 | 0.40 |
| Preprocedural medication | ||||
| Statin, % | 38.1 | 51.9 | 31.6 | 0.09 |
| ACE-I/ARB, % | 47.6 | 51.9 | 45.6 | 0.59 |
| Beta blocker, % | 29.8 | 37 | 26.3 | 0.32 |
| CCB, % | 51.2 | 55.6 | 49.1 | 0.58 |
| Antiplatelet, % | 53.6 | 74 | 43.9 | 0.01 |
| Anticoagulation, % | 13.1 | 18.5 | 10.5 | 0.31 |
Included in multivariate analysis.
LDL: low-density lipoprotein; MI: myocardial infarction; PVD: peripheral vascular disease; CAD: coronary artery disease; AF: atrial fibrillation; ACE-I: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker.
Procedural characteristics.
| All | CI | No CI |
| |
|---|---|---|---|---|
|
|
|
| ||
| No. of catheters used | 2.35 ± 1.0 | 2.85 ± 1.1 | 2.12 ± 0.87 | 0.004 |
| Catheter size, Fr | 4.31 ± 0.66 | 4.44 ± 0.80 | 4.25 ± 0.58 | 0.25 |
| Contrast volume, mL | 122.8 ± 55 | 128 ± 55 | 120 ± 55 | 0.57 |
| Fluoroscopy time, min | 18.9 ± 13.1 | 22.7 ± 14 | 17.1 ± 12.3 | 0.08 |
| LV angiogram, % | 45.2 | 48.2 | 43.9 | 0.71 |
| Ao angiogram, % | 13.1 | 11.1 | 14.0 | 0.71 |
| Urgent, % | 11.9 | 22.2 | 7.0 | 0.05 |
| IABP, % | 1.2 | 3.7 | 0 | 0.14 |
| Purpose of procedure | ||||
| Diagnostic, % | 85.7 | 74.1 | 91.2 | 0.04 |
| Interventional, % | 14.3 | 25.9 | 8.8 | 0.04 |
| Approach site | ||||
| Upper limbs, % | 81.0 | 81.5 | 80.7 | 0.93 |
| Femoral, % | 19.0 | 18.5 | 19.3 | 0.93 |
Included in multivariate analysis.
LVG: left ventriculography; AoG: aortography; IABP: intra-aortic balloon pumping.
Multivariate analysis to determine factors associated with acute CI after catheterization.
| OR | 95% CI |
| |
|---|---|---|---|
| Age (increase per 1 year) | 1.09 | 1.007–1.19 | 0.03 |
| Dyslipidemia (high LDL/statin user) | 4.46 | 1.41–16.03 | 0.01 |
| CAD | 1.64 | 0.42–6.67 | 0.47 |
| Antiplatelet use | 1.69 | 0.46–6.33 | 0.42 |
| Number of catheters used (increase per 1 catheter) | 2.21 | 1.21–4.36 | 0.01 |
| Urgent | 3.43 | 0.61–22.84 | 0.16 |
| Interventional | 1.27 | 0.24–6.4 | 0.77 |
|
| |||
| Lack-of-fit test | 0.43 (Prob > | ||
Independent predictor for CI.
CAD: coronary artery disease.
Features of MRI findings.
| Patients with CI | |
|---|---|
|
| |
| Lesions per patient | 3.89 ± 4.1 |
| Patients with a single lesion | 9 (33) |
| Patients with multiple lesions | 18 (67) |
|
| |
| Lesion location, patients | |
| Right hemisphere | 6 (22) |
| Left | 7 (26) |
| Bilateral lesions | 14 (52) |
| Anterior circulation territory | 10 (37) |
| Posterior | 7 (26) |
| Anterior and posterior | 10 (37) |